Aurisco Pharmaceutical Co Ltd (605116) — Free Cash Flow Generation Index
Aurisco Pharmaceutical Co Ltd (605116) has a Free Cash Flow Generation Index of -0.63x as of December 2024. Free cash flow of CN¥-207.87 Million represents -1% of operating cash flow (CN¥332.41 Million). Explore 605116 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Aurisco Pharmaceutical Co Ltd Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Aurisco Pharmaceutical Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see Aurisco Pharmaceutical Co Ltd cash flow conversion.
Annual Free Cash Flow Generation for Aurisco Pharmaceutical Co Ltd (2017–2024)
Year-by-year Free Cash Flow Generation Index for Aurisco Pharmaceutical Co Ltd. Check Aurisco Pharmaceutical Co Ltd (605116) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.63x | CN¥-207.87 Million | CN¥332.41 Million | CN¥540.28 Million | ▼ -400.9% |
| 2023 | 0.21x | CN¥80.13 Million | CN¥385.61 Million | CN¥305.48 Million | ▲ +169.4% |
| 2022 | -0.30x | CN¥-49.82 Million | CN¥166.41 Million | CN¥216.23 Million | ▼ -23.0% |
| 2021 | -0.24x | CN¥-49.04 Million | CN¥201.57 Million | CN¥250.61 Million | ▼ -193.7% |
| 2020 | 0.26x | CN¥55.68 Million | CN¥214.48 Million | CN¥158.80 Million | ▼ -56.5% |
| 2019 | 0.60x | CN¥107.43 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +319.5% |
| 2018 | 0.14x | CN¥15.63 Million | CN¥109.77 Million | CN¥94.14 Million | ▲ +48.4% |
| 2017 | 0.10x | CN¥11.31 Million | CN¥117.91 Million | CN¥106.60 Million | — |